These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39357835)

  • 1. The activation of asparagine synthetase by the transcription factor FOXM1 plays a pivotal role in the initiation and progression of ESCC.
    Lian JJ; Li ZX; Lin HL; Sun MC; Wu H; Feng AQ; Fang K; Wang XY; Xu AP; Chu Y; Zhang L; Chen T; Xu MD
    J Gene Med; 2024 Oct; 26(10):e3741. PubMed ID: 39357835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 Promotes Malignant Proliferation of Esophageal Squamous Cell Carcinoma Through Transcriptional Activating CDC6.
    Chen X; Chen J; Yu X; Lin G; Chen T
    DNA Cell Biol; 2022 Jul; 41(7):671-682. PubMed ID: 35639418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of asparagine synthetase under glucose-deprived conditions promotes esophageal squamous cell carcinoma development.
    Fang K; Chu Y; Zhao Z; Li Q; Li H; Chen T; Xu M
    Int J Med Sci; 2020; 17(4):510-516. PubMed ID: 32174781
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
    Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abnormal expression of circ-ARAP2 promotes ESCC progression through regulating miR-761/FOXM1 axis-mediated stemness and the endothelial-mesenchymal transition.
    Xu P; Wang L; Liu Q; Gao P; Hu F; Xie X; Jiang L; Bi R; Ding F; Yang Q; Xiao H
    J Transl Med; 2022 Jul; 20(1):318. PubMed ID: 35842667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers.
    Kimura H; Sada R; Takada N; Harada A; Doki Y; Eguchi H; Yamamoto H; Kikuchi A
    Oncogene; 2021 Jul; 40(26):4486-4502. PubMed ID: 34117362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1c promotes oesophageal cancer metastasis by transcriptionally regulating IRF1 expression.
    Zhou Y; Wang Q; Chu L; Dai W; Zhang X; Chen J; Zhang L; Ding P; Zhang X; Gu H; Zhang P; Li L; Zhang W; Li L; Lv X; Zhou D; Cai G; Chen L; Zhao K; Hu W
    Cell Prolif; 2019 Mar; 52(2):e12553. PubMed ID: 30485581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.
    Xiao Z; Jia Y; Jiang W; Wang Z; Zhang Z; Gao Y
    Thorac Cancer; 2018 Aug; 9(8):997-1004. PubMed ID: 29877046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity.
    Yao Q; Yang J; Liu T; Zhang J; Zheng Y
    FEBS Open Bio; 2019 Aug; 9(8):1392-1402. PubMed ID: 31116509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
    Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
    Yang F; Sun Z; Wang D; Du T
    BMC Cancer; 2022 Mar; 22(1):308. PubMed ID: 35317779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive bioinformatics analysis reveals the oncogenic role of FoxM1 and its impact on prognosis, immune microenvironment, and drug sensitivity in osteosarcoma.
    Shi S; Wang Q; Du X
    J Appl Genet; 2023 Dec; 64(4):779-796. PubMed ID: 37782449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma.
    Tao M; Luo J; Gu T; Yu X; Song Z; Jun Y; Gu H; Han K; Huang X; Yu W; Sun S; Zhang Z; Liu L; Chen X; Zhang L; Luo C; Wang Q
    Cell Death Dis; 2021 Sep; 12(9):845. PubMed ID: 34518524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM 1 induces Vasculogenic mimicry in esophageal cancer through β-catenin /Tcf4 signaling.
    Cheng L; Wang Q; Tao X; Qin Y; Wu Q; Zheng D; Chai D; Zhang Y; Lu D; Ci H; Wang Z; Ma J; Wang D; Cheng Z; Wu S; Tao Y
    Diagn Pathol; 2020 Feb; 15(1):14. PubMed ID: 32035486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.
    Hui MK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S
    World J Surg; 2012 Jan; 36(1):90-7. PubMed ID: 21976009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma.
    Zhao Z; Chu Y; Feng A; Zhang S; Wu H; Li Z; Sun M; Zhang L; Chen T; Xu M
    Cell Oncol (Dordr); 2024 Aug; 47(4):1295-1314. PubMed ID: 38436783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis.
    Zhang Y; Zhang Y; Ai B; Gong J; Li Y; Yu S; Cai X; Zhang L
    Oncogene; 2022 Feb; 41(6):782-796. PubMed ID: 34853466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.